Patents by Inventor Jeffrey Harold Mills

Jeffrey Harold Mills has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10907193
    Abstract: A device, method, and system for the detection of ribosome inactivating protein activity, including the ricin toxin, in a sample. According to one embodiment, the ribosome inactivating protein in the sample removes an adenine from a labeled DNA substrate to create an abasic site. An AP lyase can then cleave the DNA substrate at the abasic site, allowing the fluorophore located at or near one end of the DNA substrate and the quencher at or near the other end of the DNA substrate to spatially separate. Once the fluorophore and the quencher are sufficiently separated, the fluorophore will emit a fluorescence signal. Increasing fluorescence, indicating ribosome inactivating protein activity, will be monitored in real time using a detection system.
    Type: Grant
    Filed: May 21, 2013
    Date of Patent: February 2, 2021
    Assignee: ACUMEN DETECTION, LLC
    Inventors: Huda Sirageldin Suliman, Stacey Ann Massulik, Frances Louise Stites, Timothy Francis Moshier, Kenton Arthur Doctor, Jeffrey Harold Mills, Lisa Helen Chamberlin
  • Patent number: 9284595
    Abstract: A real-time portable and rapid detection assay to identify the presence of biologically active toxins such as botulinum toxins. The proteolytic activity of BoNT/A is measured using a peptide cleavage assay, where a fluorescent substrate is cleaved by BoNT/A, resulting in increased fluorescence. This fluorescence can be monitored in real-time using a fluorescence detection instrument, such as a real-time PCR system that has been modified to implement a detection algorithm specific to the identification of the target toxin.
    Type: Grant
    Filed: December 12, 2014
    Date of Patent: March 15, 2016
    Assignee: SRC, Inc.
    Inventors: Kenton Arthur Doctor, Stacey Ann Massulik, Frances Louise Stites, Timothy Francis Moshier, Jeffrey Harold Mills, Lisa Helen Chamberlin, Deborah Lynne Plochocki, Olivia Jennifer Barrett, Huda Sirageldin Suliman
  • Publication number: 20150159194
    Abstract: A real-time portable and rapid detection assay to identify the presence of biologically active toxins such as botulinum toxins. The proteolytic activity of BoNT/A is measured using a peptide cleavage assay, where a fluorescent substrate is cleaved by BoNT/A, resulting in increased fluorescence. This fluorescence can be monitored in real-time using a fluorescence detection instrument, such as a real-time PCR system that has been modified to implement a detection algorithm specific to the identification of the target toxin.
    Type: Application
    Filed: December 12, 2014
    Publication date: June 11, 2015
    Inventors: Kenton Arthur Doctor, Stacey Ann Massulik, Frances Louise Stites, Timothy Francis Moshier, Jeffrey Harold Mills, Lisa Helen Chamberlin, Deborah Lynne Plochocki, Olivia Jennifer Barrett, Huda Sirageldin Suliman
  • Patent number: 8962340
    Abstract: A real-time portable and rapid detection assay to identify the presence of biologically active toxins such as botulinum toxins. The proteolytic activity of BoNT/A is measured using a peptide cleavage assay, where a fluorescent substrate is cleaved by BoNT/A, resulting in increased fluorescence. This fluorescence can be monitored in real-time using a fluorescence detection instrument, such as a real-time PCR system that has been modified to implement a detection algorithm specific to the identification of the target toxin.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: February 24, 2015
    Assignee: SRC, Inc.
    Inventors: Kenton Arthur Doctor, Stacey Ann Massulik, Frances Louise Stites, Timothy Francis Moshier, Jeffrey Harold Mills, Lisa Helen Chamberlin, Deborah L. Plochocki, Olivia Jennifer Barrett, Huda Sirageldin Suliman
  • Publication number: 20140154812
    Abstract: A real-time portable and rapid detection assay to identify the presence of biologically active toxins such as botulinum toxins. The proteolytic activity of BoNT/A is measured using a peptide cleavage assay, where a fluorescent substrate is cleaved by BoNT/A, resulting in increased fluorescence. This fluorescence can be monitored in real-time using a fluorescence detection instrument, such as a real-time PCR system that has been modified to implement a detection algorithm specific to the identification of the target toxin.
    Type: Application
    Filed: March 15, 2013
    Publication date: June 5, 2014
    Inventors: Kenton Arthur Doctor, Stacey Ann Massulik, Frances Louise Stites, Timothy Francis Moshier, Jeffrey Harold Mills, Lisa Helen Chamberlin, Deborah L. Plochocki, Olivia Jennifer Barrett, Huda Sirageldin Suliman
  • Publication number: 20140065623
    Abstract: A device, method, and system for the detection of ribosome inactivating protein activity, including the ricin toxin, in a sample. According to one embodiment, the ribosome inactivating protein in the sample removes an adenine from a labeled DNA substrate to create an abasic site. An AP lyase can then cleave the DNA substrate at the abasic site, allowing the fluorophore located at or near one end of the DNA substrate and the quencher at or near the other end of the DNA substrate to spatially separate. Once the fluorophore and the quencher are sufficiently separated, the fluorophore will emit a fluorescence signal. Increasing fluorescence, indicating ribosome inactivating protein activity, will be monitored in real time using a detection system.
    Type: Application
    Filed: May 21, 2013
    Publication date: March 6, 2014
    Applicant: SRC, Inc.
    Inventors: Huda Sirageldin Suliman, Stacey Ann Massulik, Frances Louise Stites, Timothy Francis Moshier, Kenton Arthur Doctor, Jeffrey Harold Mills, Lisa Helen Chamberlin